BRIEF published on 04/22/2026 at 22:10, 6 months 9 days ago Abivax to Present Data on Obefazimod at Digestive Disease Week® Abivax Obefazimod Ulcerative Colitis Phase 3 Clinical Trials DDW 2026
PRESS RELEASE published on 04/22/2026 at 22:05, 6 months 9 days ago Abivax to Present Data on Obefazimod at Digestive Disease Week® Abivax to present data on Obefazimod at Digestive Disease Week, showcasing efficacy, safety, and patient outcomes from Phase 3 ABTECT program and preclinical anti-fibrotic models Abivax Obefazimod Clinical Trials Digestive Disease Week Inflammatory Bowel Disease
BRIEF published on 04/20/2026 at 22:10, 6 months 11 days ago Abivax: Annual General Meeting scheduled for May 11, 2026 Biotechnology Abivax Obefazimod General Assembly Preparatory Documents
BRIEF published on 04/20/2026 at 22:10, 6 months 11 days ago Abivax Prepares for General Meeting with Document Release Biotechnology Abivax Ulcerative Colitis General Meeting Preparatory Documents
PRESS RELEASE published on 04/20/2026 at 22:05, 6 months 11 days ago Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents Abivax informs shareholders about the Annual Ordinary and Extraordinary General Meeting on May 11, 2026, in Paris, providing access to preparatory documents Shareholders Abivax General Meeting Clinical-stage Biotechnology Preparatory Documents
BRIEF published on 04/17/2026 at 15:48, 6 months 14 days ago JP Morgan Chase & Co. crosses the 5% threshold in ABIVAX Voting Rights Abivax Threshold Crossing JP Morgan Indirect Ownership
BRIEF published on 04/17/2026 at 10:42, 6 months 14 days ago JP Morgan Chase & Co. reduces its stake in ABIVAX Euronext Paris Voting Rights Abivax Threshold Crossing JP Morgan
BRIEF published on 04/08/2026 at 12:17, 6 months 23 days ago Abivax presents the results of the ABTECT trial Abivax Obefazimod Ulcerative Colitis Clinical Trial Tolérance
BRIEF published on 04/01/2026 at 22:10, 7 months ago Abivax submits its financial reports to French and American regulators AMF Abivax Financial Reports Regulation DRY
BRIEF published on 04/01/2026 at 22:10, 7 months ago Abivax Files Financial Documents with French and U.S. Regulatory Bodies Abivax Financial Reports Annual Report Universal Registration Document Regulatory Agencies
Published on 10/30/2026 at 23:35, 2 days 2 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 2 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 2 days 7 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 10 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 10:35, 15 hours 27 minutes ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 21 hours 2 minutes ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 1 day 9 hours ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 2 days 3 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 2 days 3 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 2 days 14 hours ago Capital increase through exercise of subscription rights
